Størstedelen af erfaringen med palivizumab inklusiv de centrale fase III kliniske studier er opnået med 5 injektioner pr. sæson (se punkt 5. 1).
The majority of experience including the pivotal phase III clinical trials with palivizumab has been gained with 5 injections during one season (see section 5.1).